Structure-Based Design of 2‑Aminopyridine Oxazolidinones as Potent and Selective Tankyrase Inhibitors by Huang, Hongbing, Guzman-Perez, Angel, Acquaviva, Lisa, Berry, Virginia, Bregman, Howard, Dovey, Jennifer, Gunaydin, Hakan, Huang, Xin, Huang, Liyue, Saffran, Doug, Serafino, Randy, Schneider, Steve, Wilson, Cindy, DiMauro, Erin F

Get full text

Abstract 1771: Targeting oncogenic transcription in prostate cancer with a novel, oral bioavailable, and ultra-selective CDK9 inhibitor by Richters, André, Freeman, David, Lee, Christina, Kabinger, Florian, Doyle, Shelby, Leifer, Becky, Mikochik, Peter, Jagannathan, Sajjeev, Koren, Jost Vrabic, Karlin, Kristen, Olson, Calla M., Wilfong, Christopher, Lin, Charles Y., Saffran, Doug, Vacca, Joseph, Bischofberger, Norbert, Pop, Marius, Koehler, Angela N.

Get full text

Abstract 1795: Characterization of a novel series of potent, selective inhibitors of wild type and mutant/fusion anaplastic lymphoma kinase by Wilcoxen, Keith M., Brake, Rachael L., Saffran, Doug, Teffera, Yohannes, Choquette, Deborah, Whittington, Doug, Yu, Violeta, Romero, Karina, Bode, Christiane, Stellwagen, John, Potashman, Michelle, Emkey, Renee, Andrews, Paul, Drew, Allison E., Xu, Man, Szilvassy, Stephen, Al-Assad, Samer, Lewis, Richard T.

Get full text

Structure-Based Design of Potent and Selective CK1γ Inhibitors by Huang, Hongbing, Acquaviva, Lisa, Berry, Virginia, Bregman, Howard, Chakka, Nagasree, O’Connor, Anne, DiMauro, Erin F, Dovey, Jennifer, Epstein, Oleg, Grubinska, Barbara, Goldstein, Jon, Gunaydin, Hakan, Hua, Zihao, Huang, Xin, Huang, Liyue, Human, Jason, Long, Alex, Newcomb, John, Patel, Vinod F, Saffran, Doug, Serafino, Randy, Schneider, Steve, Strathdee, Craig, Tang, Jin, Turci, Susan, White, Ryan, Yu, Violeta, Zhao, Huilin, Wilson, Cindy, Martin, Matthew W

Get full text